Our result that Upf1 phosphorylation was maintained at the early stage of fatty liver but lost in severe fatty liver supports the conclusion that loss of NMD activity may explain low post-transcriptional regulations in severe fatty liver diseases and possibly other chronic liver diseases including MASH, liver fibrosis and liver cancer. Here, UPF1 is linked to liver cancer.